Helus Pharma Appoints Michael Halstead as Chief Executive Officer

Former President of Intra-Cellular Therapies, Inc. was instrumental in building and scaling the company, which was subsequently acquired by Johnson & Johnson

Experienced executive with a proven track record of guiding pharmaceutical companies through late-stage clinical development and commercialization